A detailed history of New Edge Advisors, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 611 shares of ELAN stock, worth $8,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares
611
Previous 611 -0.0%
Holding current value
$8,541
Previous $8,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$12.93 - $18.45 $1,564 - $2,232
-121 Reduced 16.53%
611 $8,000
Q1 2024

May 14, 2024

SELL
$14.37 - $16.46 $2,371 - $2,715
-165 Reduced 18.39%
732 $11,000
Q4 2023

Feb 13, 2024

BUY
$8.6 - $14.94 $5,134 - $8,919
597 Added 199.0%
897 $13,000
Q3 2023

Nov 14, 2023

BUY
$9.81 - $12.62 $2,943 - $3,785
300 New
300 $3,000
Q4 2022

Feb 14, 2023

BUY
$11.49 - $13.65 $14,799 - $17,581
1,288 New
1,288 $15,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.